DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620)

DongKoo Bio & Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2017
Market Capitalization	133,643	156,349	169,609	232,556	240,580	-
Market Cap Growth	19.22%	-7.82%	-27.07%	-3.34%	-	-
Enterprise Value	179,672	172,036	175,056	221,869	244,593	-
Last Close Price	4895.00	5660.00	6009.59	7906.48	7931.13	-
PE Ratio	10.37	13.24	25.22	23.96	24.55	-
PS Ratio	0.56	0.72	0.87	1.50	1.73	-
PB Ratio	1.19	1.42	1.66	2.32	2.54	-
P/TBV Ratio	1.92	1.57	1.82	2.40	2.60	-
P/FCF Ratio	-	-	14.32	17.05	108.33	-
P/OCF Ratio	16.02	43.61	10.08	12.99	32.13	-
EV/Sales Ratio	0.75	0.80	0.90	1.43	1.76	-
EV/EBITDA Ratio	9.16	8.33	7.79	16.82	20.19	-
EV/EBIT Ratio	13.46	11.77	10.40	27.26	32.13	-
EV/FCF Ratio	-11.63	-	14.78	16.27	110.14	-
Debt / Equity Ratio	0.62	0.40	0.34	0.24	0.25	0.40
Debt / EBITDA Ratio	3.52	2.12	1.53	1.84	1.96	0.97
Debt / FCF Ratio	-	-	2.90	1.78	10.69	1.73
Asset Turnover	1.19	1.19	1.19	1.04	-	1.44
Inventory Turnover	2.36	2.26	2.74	2.52	-	3.54
Quick Ratio	0.47	0.60	0.83	0.97	1.16	0.93
Current Ratio	0.93	1.21	1.32	1.48	1.79	1.29
Return on Equity (ROE)	11.94%	11.11%	6.54%	9.58%	-	35.35%
Return on Assets (ROA)	4.17%	5.03%	6.44%	3.40%	-	11.83%
Return on Capital (ROIC)	5.20%	6.29%	8.07%	4.19%	-	17.28%
Earnings Yield	9.64%	7.55%	3.90%	4.01%	3.80%	-
FCF Yield	-11.56%	-6.56%	6.98%	5.86%	0.92%	-
Dividend Yield	2.45%	2.12%	-	-	-	-
Payout Ratio	25.47%	25.72%	42.39%	10.11%	10.32%	-
Buyback Yield / Dilution	0.44%	0.48%	1.78%	0.12%	-25.96%	20.35%
Total Shareholder Return	2.89%	2.60%	1.78%	0.12%	-25.96%	20.35%

Source: S&P Capital IQ. Standard template. Financial Sources.